For patients

“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767419”

Why screening for colon cancer is important?

A good prognosis is directly related to early detection and the timing of diagnosis in colon cancer patients. When colon cancer is detected at early localized stages (I-II) the 5 year survival rate is 90% while this rate drops to 12% when patients are diagnosed at stage IV and metastasis. These data show the importance of screening in colon cancer at a treatable stage [13].

Intended use

ColoFast is indicated to screen adults of either sex, 50 years or older, who are at typical average-risk for CRC. ColoFast is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high-risk individuals

Is ColoFast safe for me?

Yes. It is a minimal invasive test that only requires a simple blood extraction. It represents advantages versus other screening methods, such as those based on direct visualization of colorectal area, which are risky and could have potential harms for the patients, and those that use fecal samples, which have a low compliance mainly due to the difficulty of sample collection.

Could ColoFast prevent cancer?

Yes. ColoFast helps to find premalignant lesions (i.e. advanced adenomas) or colon cancer. In fact, most colon cancers develop slowly over several years but before cancer appears, a polyp—a non-cancerous growth—usually develops on the inner lining of the colon or rectum. Advanced adenomas are polyps with high potential of malignancy. Finding and removing premalignant lesions through a simple colonoscopy prevents colon cancer whereas detection of early stage improves patient prognosis.


  • 13 American Cancer Society. Cancer statistics, 2014. Colorectal facts and figures, 2011-2014.

Comments are closed, but trackbacks and pingbacks are open.